Kelly Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-250
Closed -$122K 390
2024
Q2
$122K Buy
250
+48
+24% +$24.1K 0.04% 129
2024
Q1
$109K Sell
202
-2
-1% -$1.09K 0.04% 142
2023
Q4
$113K Buy
204
+14
+7% +$6.57K 0.05% 129
2023
Q3
$83.1K Sell
190
-18
-9% -$8.98K 0.04% 135
2023
Q2
$104K Buy
208
+15
+8% +$7.19K 0.05% 118
2023
Q1
$96.5K Buy
193
+1
+0.5% +$479 0.05% 124
2022
Q4
$78.3K Buy
192
+52
+37% +$20.2K 0.04% 136
2022
Q3
$45.6K Sell
140
-2
-1% -$735 0.03% 161
2022
Q2
$49.8K Sell
142
-13
-8% -$5.3K 0.03% 164
2022
Q1
$84.8K Sell
155
-17
-10% -$8.94K 0.04% 133
2021
Q4
$113K Buy
172
+75
+77% +$47.1K 0.05% 118
2021
Q3
$60.3K Sell
97
-4
-4% -$2.69K 0.03% 137
2021
Q2
$63.8K Buy
101
+85
+531% +$46.9K 0.04% 135
2021
Q1
$7.83K Sell
16
-1
-6% -$501 ﹤0.01% 337
2020
Q4
$8.5K Buy
+17
New +$7.61K 0.01% 296

Other funds holding IDXX

Kelly Financial Services's IDXX Position: Q3 2024 in Review

Kelly Financial Services sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 250 shares — an estimated $122K sold.

Kelly Financial Services first reported a position in IDXX in Q4 2020 and held it in 15 quarters. The position peaked at $122K in Q2 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Kelly Financial Services reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 250 Idexx Laboratories shares in Q3 2024, an estimated $122K.
  • Kelly Financial Services first reported a position in Idexx Laboratories in Q4 2020 and held it in 15 quarters.
  • Kelly Financial Services's Idexx Laboratories position peaked at $122K in Q2 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.